Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease

Nav

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

01/2003 - 12/2005

Data type

Scientific literature

Keywords

HIV and AIDS, Health care costs

Citation

Authors

Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP

Journal

J Acquir Immune Defic Syndr (1988)

Volume

Issue

Pages

69-77

Publication year

2005

Suggested citation

Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP. Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease. J Acquir Immune Defic Syndr (1988). 2005; 39(1): 69-77.

DOI

10.1097/01.qai.0000160406.08924.a2

PMID

15851916

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease

Nav